Plain-English translation of NCT07515781 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a medical device called the VivaStent, which is a small tube placed inside a narrowed vein in the brain to help restore normal blood flow. Some patients experience a pulsating ringing sound in their ear (called pulsatile tinnitus) when a vein becomes too narrow, and this treatment aims to relieve that symptom by opening up the blocked vessel.
Pulsatile tinnitus caused by vein narrowing can be very distressing and interfere with quality of life, yet treatment options are limited. This trial exists to see whether the VivaStent can safely and effectively reduce this bothersome symptom.
You likely qualify if…
You likely don't qualify if…
You will have an outpatient procedure where doctors use a catheter to place the VivaStent in the narrowed vein in your brain while monitoring blood flow and pressure. You will stay in the hospital overnight for observation, then return for follow-up visits at 1 month, 3 months, and 12 months after the procedure. At each visit, you will complete questionnaires about your tinnitus symptoms, have imaging scans at 3 and 12 months, and be checked for any side effects.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
France